AVID BIOSERVICES INC (CDMO) Forecast, Price Target & Analyst Ratings

NASDAQ:CDMO • US05368M1062

Current stock price

12.49 USD
+0.01 (+0.08%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVID BIOSERVICES INC (CDMO).

Forecast Snapshot

Consensus Price Target

Price Target
$12.75
+ 2.08% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 22, 2025
Period
Q3 / 2025
EPS Estimate
-$0.06
Revenue Estimate
42.204M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
74.55%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$12.75
Upside
+ 2.08%
From current price of $12.49 to mean target of $12.75, Based on 11 analyst forecasts
Low
$12.63
Median
$12.75
High
$13.13

Price Target Revisions

1 Month
0.00%
3 Months
-7.41%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for CDMO. The average price target is 12.75 USD. This implies a price increase of 2.08% is expected in the next year compared to the current price of 12.49.
The average price target has been revised downward by 7.41% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CDMO Current Analyst RatingCDMO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

CDMO Historical Analyst RatingsCDMO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
74.55%
CDMO was analyzed by 11 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CDMO.
In the previous month the buy percentage consensus was at a similar level.
CDMO was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-11-07William BlairReiterate Market Perform
2024-11-07RBC CapitalDowngrade Outperform -> Sector Perform
2024-09-10William BlairReiterate Market Perform
2024-09-10RBC CapitalMaintains Outperform -> Outperform
2024-09-10Stephens & Co.Reiterate Overweight -> Overweight
2024-07-03RBC CapitalReiterate Outperform -> Outperform
2024-04-30RBC CapitalMaintains Outperform -> Outperform
2024-03-11Stephens & Co.Maintains Overweight -> Overweight
2024-03-07RBC CapitalReiterate Outperform -> Outperform
2023-12-08KeybancMaintains Overweight -> Overweight
2023-12-08RBC CapitalMaintains Outperform -> Outperform
2023-12-08Craig-HallumMaintains Buy -> Buy
2023-09-28William BlairInitiate Market Perform
2023-09-08RBC CapitalMaintains Outperform -> Outperform
2023-06-22RBC CapitalMaintains Outperform -> Outperform
2023-06-22Stephens & Co.Reiterate Overweight -> Overweight
2023-03-14KeybancUpgrade Sector Weight -> Overweight
2023-03-14RBC CapitalReiterate Outperform
2023-03-14Stephens & Co.Reiterate Overweight
2022-12-07RBC CapitalMaintains Outperform
2022-06-30RBC CapitalMaintains Outperform
2022-03-09Stephens & Co.Maintains Overweight
2021-12-08KeybancDowngrade Overweight -> Sector Weight
2021-12-08RBC CapitalMaintains Outperform
2021-12-08Craig-HallumMaintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 22, 2025
Period
Q3 / 2025
EPS Estimate
-$0.06
Revenue Estimate
42.204M
Revenue Q2Q
24.81%
EPS Q2Q
32.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
-2.16%
Revenue (3 Months)
0.42%
EPS (1 Month)
-9.09%
EPS (3 Months)
-50.00%

Next Earnings Summary

CDMO is expected to report earnings on 4/22/2025. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 42.20M USD.
The next earnings revenue estimate has been revised upward by 0.42% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
CDMO revenue by date.CDMO revenue by date.
119.6M
24.71%		149.3M
24.83%		139.911M
-6.29%		166.37M
18.91%		194.26M
16.76%		234.86M
20.90%		307.28M
30.84%		385.63M
25.50%		482.04M
25.00%		597.73M
24.00%
EBITDA
YoY % growth
CDMO ebitda by date.CDMO ebitda by date.
19.88M
27.03%		10.81M
-45.62%		-7.569M
-170.02%		12.718M
268.03%		28.906M
127.28%		50.053M
73.16%		N/AN/AN/AN/A
EBIT
YoY % growth
CDMO ebit by date.CDMO ebit by date.
15.4M
26.23%		3.6M
-76.62%		-18.678M
-618.83%		-9.648M
48.35%		-270.3K
97.20%		17.124M
6,435.18%		30.728M
79.44%		48.204M
56.87%		72.307M
50.00%		104.6M
44.66%
Operating Margin
CDMO operating margin by date.CDMO operating margin by date.
12.88%2.41%-13.35%-5.80%-0.14%7.29%10.00%12.50%15.00%17.50%
EPS
YoY % growth
CDMO eps by date.CDMO eps by date.
0.21
425.00%		0.01
-95.24%		-2.21
-22,200.00%		-0.31
86.15%		-0.16
46.67%		0.18
212.50%		N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.06
32.00%		-0.04
98.16%		-0.05
43.33%		-0.11
58.44%		-0.03
58.33%		0.02
157.14%		0.03
160.00%		-0.02
81.82%		0.03
220.00%		0.09
350.00%
Revenue
Q2Q % growth		42.204M
24.81%		48.759M
13.46%		48.06M
19.63%		39.26M
17.26%		50.082M
18.67%		58.575M
20.13%		58.324M
21.36%		47.222M
20.28%		59.596M
19.00%		67.467M
15.18%
EBITDA
Q2Q % growth		4.451M
4.70%		6.784M
-30.88%		6.609M
1,695.92%		2.268M
138.87%		8.054M
80.95%		11.335M
67.08%		12.501M
89.15%		7.862M
246.65%		12.982M
61.19%		17.913M
58.03%
EBIT
Q2Q % growth		-1.906M
52.34%		359.04K
127.75%		-515.1K
79.03%		-4.957M
60.75%		464.61K
124.38%		3.838M
968.96%		5.353M
1,139.22%		240.72K
104.86%		5.127M
1,003.51%		11.237M
192.78%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CDMO Yearly Revenue VS EstimatesCDMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
CDMO Yearly EPS VS EstimatesCDMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
27.71%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
18.30%
Revenue Next 5 Year
22.14%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
71.06%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

AVID BIOSERVICES INC / CDMO Forecast FAQ

What is the average price target for AVID BIOSERVICES INC (CDMO) stock?

11 analysts have analysed CDMO and the average price target is 12.75 USD. This implies a price increase of 2.08% is expected in the next year compared to the current price of 12.49.

When does AVID BIOSERVICES INC (CDMO) report earnings?

AVID BIOSERVICES INC (CDMO) will report earnings on 2025-04-22, after the market close.

Can you provide the consensus estimates for AVID BIOSERVICES INC next earnings?

The consensus EPS estimate for the next earnings of AVID BIOSERVICES INC (CDMO) is -0.06 USD and the consensus revenue estimate is 42.20M USD.

What is the consensus rating for CDMO stock?

The consensus rating for AVID BIOSERVICES INC (CDMO) is 74.5455 / 100 . This indicates that analysts generally have a positive outlook on the stock.